ID   UB2E1_HUMAN             Reviewed;         193 AA.
AC   P51965; B2RBX4; C9J8K2; K4DI90;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   07-APR-2021, entry version 204.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 E1;
DE            EC=2.3.2.23 {ECO:0000269|PubMed:20061386};
DE   AltName: Full=(E3-independent) E2 ubiquitin-conjugating enzyme E1;
DE            EC=2.3.2.24 {ECO:0000269|PubMed:17588522};
DE   AltName: Full=E2 ubiquitin-conjugating enzyme E1;
DE   AltName: Full=UbcH6;
DE   AltName: Full=Ubiquitin carrier protein E1;
DE   AltName: Full=Ubiquitin-protein ligase E1;
GN   Name=UBE2E1; Synonyms=UBCH6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8576257; DOI=10.1074/jbc.271.5.2795;
RA   Nuber U., Schwarz S., Kaiser P., Schneider R., Scheffner M.;
RT   "Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and
RT   characterization of their interaction with E6-AP and RSP5.";
RL   J. Biol. Chem. 271:2795-2800(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Cervix carcinoma, Colon, and Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND ISGYLATION AT LYS-136.
RX   PubMed=16428300; DOI=10.1093/jb/mvi172;
RA   Takeuchi T., Iwahara S., Saeki Y., Sasajima H., Yokosawa H.;
RT   "Link between the ubiquitin conjugation system and the ISG15 conjugation
RT   system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme.";
RL   J. Biochem. 138:711-719(2005).
RN   [7]
RP   CATALYTIC ACTIVITY AS E3-INDEPENDENT E2 UBIQUITIN-CONJUGATING ENZYME.
RX   PubMed=17588522; DOI=10.1016/j.molcel.2007.05.014;
RA   Hoeller D., Hecker C.M., Wagner S., Rogov V., Doetsch V., Dikic I.;
RT   "E3-independent monoubiquitination of ubiquitin-binding proteins.";
RL   Mol. Cell 26:891-898(2007).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=18845142; DOI=10.1016/j.yexcr.2008.09.011;
RA   Espinosa A., Oke V., Elfving A., Nyberg F., Covacu R., Wahren-Herlenius M.;
RT   "The autoantigen Ro52 is an E3 ligase resident in the cytoplasm but enters
RT   the nucleus upon cellular exposure to nitric oxide.";
RL   Exp. Cell Res. 314:3605-3613(2008).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20061386; DOI=10.1074/jbc.m109.089003;
RA   David Y., Ziv T., Admon A., Navon A.;
RT   "The E2 ubiquitin-conjugating enzymes direct polyubiquitination to
RT   preferred lysines.";
RL   J. Biol. Chem. 285:8595-8604(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13] {ECO:0007744|PDB:3BZH}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS), AND AUTOUBIQUITINATION.
RX   PubMed=22496338; DOI=10.1074/mcp.o111.013706;
RA   Sheng Y., Hong J.H., Doherty R., Srikumar T., Shloush J., Avvakumov G.V.,
RA   Walker J.R., Xue S., Neculai D., Wan J.W., Kim S.K., Arrowsmith C.H.,
RA   Raught B., Dhe-Paganon S.;
RT   "A human ubiquitin conjugating enzyme (E2)-HECT E3 ligase structure-
RT   function screen.";
RL   Mol. Cell. Proteomics 11:329-341(2012).
CC   -!- FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its
CC       covalent attachment to other proteins. Catalyzes the covalent
CC       attachment of ISG15 to other proteins. Mediates the selective
CC       degradation of short-lived and abnormal proteins. In vitro also
CC       catalyzes 'Lys-48'-linked polyubiquitination.
CC       {ECO:0000269|PubMed:16428300, ECO:0000269|PubMed:20061386}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine +
CC         [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-
CC         activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-
CC         conjugating enzyme]-L-cysteine.; EC=2.3.2.23;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-
CC         ProRule:PRU10133, ECO:0000269|PubMed:20061386};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-
CC         cysteine + N(6)-monoubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.24; Evidence={ECO:0000269|PubMed:17588522};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Interacts with RNF14.
CC   -!- INTERACTION:
CC       P51965; Q96FW1: OTUB1; NbExp=3; IntAct=EBI-348546, EBI-1058491;
CC       P51965; Q8N7H5: PAF1; NbExp=2; IntAct=EBI-348546, EBI-2607770;
CC       P51965; Q9Y3C5: RNF11; NbExp=2; IntAct=EBI-348546, EBI-396669;
CC       P51965; Q5VTR2: RNF20; NbExp=2; IntAct=EBI-348546, EBI-2372238;
CC       P51965; Q96BH1: RNF25; NbExp=3; IntAct=EBI-348546, EBI-2129220;
CC       P51965; Q8ND25: ZNRF1; NbExp=3; IntAct=EBI-348546, EBI-2129250;
CC       P51965; Q99PZ6: ospG; Xeno; NbExp=3; IntAct=EBI-348546, EBI-9316527;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18845142}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P51965-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51965-2; Sequence=VSP_045884;
CC       Name=3;
CC         IsoId=P51965-3; Sequence=VSP_047200;
CC   -!- PTM: ISGylation suppresses ubiquitin E2 enzyme activity.
CC       {ECO:0000269|PubMed:16428300}.
CC   -!- PTM: Autoubiquitinated in vitro. {ECO:0000269|PubMed:22496338}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X92963; CAA63539.1; -; mRNA.
DR   EMBL; AK314854; BAG37371.1; -; mRNA.
DR   EMBL; AC020626; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC124914; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64329.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64331.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64332.1; -; Genomic_DNA.
DR   EMBL; BC009139; AAH09139.1; -; mRNA.
DR   EMBL; BI223271; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BI666638; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS2638.1; -. [P51965-1]
DR   CCDS; CCDS2639.1; -. [P51965-3]
DR   CCDS; CCDS56244.1; -. [P51965-2]
DR   RefSeq; NP_001189405.1; NM_001202476.1. [P51965-2]
DR   RefSeq; NP_003332.1; NM_003341.4. [P51965-1]
DR   RefSeq; NP_872607.1; NM_182666.2. [P51965-3]
DR   PDB; 1XR9; X-ray; 1.79 A; C=83-91.
DR   PDB; 3BZH; X-ray; 1.60 A; A=1-193.
DR   PDB; 4JJQ; X-ray; 1.95 A; B=5-14.
DR   PDB; 5LBN; X-ray; 1.42 A; A=37-193.
DR   PDB; 6FGA; X-ray; 2.82 A; I/J/K/L/M/N/O=37-193.
DR   PDBsum; 1XR9; -.
DR   PDBsum; 3BZH; -.
DR   PDBsum; 4JJQ; -.
DR   PDBsum; 5LBN; -.
DR   PDBsum; 6FGA; -.
DR   SMR; P51965; -.
DR   BioGRID; 113172; 151.
DR   CORUM; P51965; -.
DR   IntAct; P51965; 76.
DR   MINT; P51965; -.
DR   STRING; 9606.ENSP00000303709; -.
DR   BindingDB; P51965; -.
DR   ChEMBL; CHEMBL4105876; -.
DR   MoonDB; P51965; Predicted.
DR   iPTMnet; P51965; -.
DR   PhosphoSitePlus; P51965; -.
DR   SwissPalm; P51965; -.
DR   BioMuta; UBE2E1; -.
DR   DMDM; 1717857; -.
DR   EPD; P51965; -.
DR   jPOST; P51965; -.
DR   MassIVE; P51965; -.
DR   MaxQB; P51965; -.
DR   PaxDb; P51965; -.
DR   PeptideAtlas; P51965; -.
DR   PRIDE; P51965; -.
DR   ProteomicsDB; 12713; -. [P51965-1]
DR   ProteomicsDB; 56463; -. [P51965-1]
DR   ProteomicsDB; 9057; -.
DR   Antibodypedia; 45210; 118 antibodies.
DR   CPTC; P51965; 3 antibodies.
DR   Ensembl; ENST00000306627; ENSP00000303709; ENSG00000170142. [P51965-1]
DR   Ensembl; ENST00000346855; ENSP00000329113; ENSG00000170142. [P51965-3]
DR   Ensembl; ENST00000424381; ENSP00000411351; ENSG00000170142. [P51965-2]
DR   GeneID; 7324; -.
DR   KEGG; hsa:7324; -.
DR   UCSC; uc003cch.4; human. [P51965-1]
DR   CTD; 7324; -.
DR   DisGeNET; 7324; -.
DR   GeneCards; UBE2E1; -.
DR   HGNC; HGNC:12477; UBE2E1.
DR   HPA; ENSG00000170142; Low tissue specificity.
DR   MIM; 602916; gene.
DR   neXtProt; NX_P51965; -.
DR   OpenTargets; ENSG00000170142; -.
DR   PharmGKB; PA37127; -.
DR   VEuPathDB; HostDB:ENSG00000170142.11; -.
DR   eggNOG; KOG0417; Eukaryota.
DR   GeneTree; ENSGT00940000156415; -.
DR   HOGENOM; CLU_030988_14_4_1; -.
DR   InParanoid; P51965; -.
DR   OMA; IVFRTRI; -.
DR   PhylomeDB; P51965; -.
DR   TreeFam; TF101117; -.
DR   BRENDA; 2.3.2.B6; 2681.
DR   PathwayCommons; P51965; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-141430; Inactivation of APC/C via direct inhibition of the APC/C complex.
DR   Reactome; R-HSA-174048; APC/C:Cdc20 mediated degradation of Cyclin B.
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-176407; Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase.
DR   Reactome; R-HSA-176408; Regulation of APC/C activators between G1/S and early anaphase.
DR   Reactome; R-HSA-176409; APC/C:Cdc20 mediated degradation of mitotic proteins.
DR   Reactome; R-HSA-176412; Phosphorylation of the APC/C.
DR   Reactome; R-HSA-179409; APC-Cdc20 mediated degradation of Nek2A.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-8853884; Transcriptional Regulation by VENTX.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   Reactome; R-HSA-9687136; Aberrant regulation of mitotic exit in cancer due to RB1 defects.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P51965; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 7324; 10 hits in 1005 CRISPR screens.
DR   ChiTaRS; UBE2E1; human.
DR   EvolutionaryTrace; P51965; -.
DR   GeneWiki; UBE2E1; -.
DR   GenomeRNAi; 7324; -.
DR   Pharos; P51965; Tbio.
DR   PRO; PR:P51965; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P51965; protein.
DR   Bgee; ENSG00000170142; Expressed in embryo and 247 other tissues.
DR   ExpressionAtlas; P51965; baseline and differential.
DR   Genevisible; P51965; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042296; F:ISG15 transferase activity; IDA:HGNC-UCL.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; IDA:BHF-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0031145; P:anaphase-promoting complex-dependent catabolic process; TAS:Reactome.
DR   GO; GO:0033523; P:histone H2B ubiquitination; IDA:UniProtKB.
DR   GO; GO:0010390; P:histone monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0032020; P:ISG15-protein conjugation; IDA:HGNC-UCL.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:BHF-UCL.
DR   GO; GO:0007096; P:regulation of exit from mitosis; TAS:Reactome.
DR   GO; GO:1901990; P:regulation of mitotic cell cycle phase transition; TAS:Reactome.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:Reactome.
DR   CDD; cd00195; UBCc; 1.
DR   DisProt; DP02191; -.
DR   Gene3D; 3.10.110.10; -; 1.
DR   IDEAL; IID00633; -.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR023313; UBQ-conjugating_AS.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS00183; UBC_1; 1.
DR   PROSITE; PS50127; UBC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Isopeptide bond; Nucleotide-binding; Nucleus; Reference proteome;
KW   Transferase; Ubl conjugation; Ubl conjugation pathway.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:21406692"
FT   CHAIN           2..193
FT                   /note="Ubiquitin-conjugating enzyme E2 E1"
FT                   /id="PRO_0000082470"
FT   DOMAIN          47..193
FT                   /note="UBC core"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00388"
FT   COMPBIAS        9..18
FT                   /note="Poly-Ser"
FT   ACT_SITE        131
FT                   /note="Glycyl thioester intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00388,
FT                   ECO:0000255|PROSITE-ProRule:PRU10133"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:21406692"
FT   CROSSLNK        136
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ISG15)"
FT   VAR_SEQ         1..50
FT                   /note="MSDDDSRASTSSSSSSSSNQQTEKETNTPKKKESKVSMSKNSKLLSTSAK
FT                   -> MKEVGRPREVRGRPGKS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_045884"
FT   VAR_SEQ         51..67
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047200"
FT   VARIANT         25
FT                   /note="E -> D (in dbSNP:rs36060625)"
FT                   /id="VAR_061868"
FT   CONFLICT        131
FT                   /note="C -> R (in Ref. 5; BI223271)"
FT                   /evidence="ECO:0000305"
FT   HELIX           22..24
FT                   /evidence="ECO:0007744|PDB:3BZH"
FT   HELIX           42..44
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   HELIX           47..61
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   STRAND          67..74
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   STRAND          78..84
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   TURN            90..93
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   STRAND          95..101
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   TURN            104..107
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   STRAND          112..117
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   HELIX           133..135
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   TURN            136..138
FT                   /evidence="ECO:0007744|PDB:3BZH"
FT   HELIX           145..157
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   HELIX           167..175
FT                   /evidence="ECO:0007744|PDB:5LBN"
FT   HELIX           177..191
FT                   /evidence="ECO:0007744|PDB:5LBN"
SQ   SEQUENCE   193 AA;  21404 MW;  2FBC50BE2A6A0008 CRC64;
     MSDDDSRAST SSSSSSSSNQ QTEKETNTPK KKESKVSMSK NSKLLSTSAK RIQKELADIT
     LDPPPNCSAG PKGDNIYEWR STILGPPGSV YEGGVFFLDI TFTPEYPFKP PKVTFRTRIY
     HCNINSQGVI CLDILKDNWS PALTISKVLL SICSLLTDCN PADPLVGSIA TQYMTNRAEH
     DRMARQWTKR YAT
//
